This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

MetLife Buys Back Its Stock; Should You Now Buy MetLife?

Stocks in this article: MET SPY PRU

NEW YORK (TheStreet) -- Timing is everything, and right now may be the right time to add MetLife (MET) to your portfolio.

The insurer's stock is cheap. It currently trades around $54.75, up 2% for the year to date. It has a 2014 price-to-earnings ratio of 9.6 and a price-to-book value of 1.0, making it one of the cheapest stocks in the S&P 500 (SPY), the exchange-traded fund proxy for the S&P 500.

The insurance company also has a 2.55% dividend yield, offers global reach, a diverse product line and sound management. MetLife even announced a $1 billion share buyback program. The last time MetLife repurchased shares was in 2008, the year the financial crisis started.

In addition, this week the U.S. Senate passed legislation that would give regulators more flexibility in how they apply capital standards to insurers. It now needs approval in the House of Representatives.

If signed into law by President Obama, the new law would place high capital standards on entities deemed non-bank systemically important financial institutions, or SIFIs. MetLife has not been designated a SIFI but competitor Prudential (PRU) has been.

The Federal Reserve is in the process of working out how to apply capital standards to help financial institutions withstand future economic meltdowns. According to a MetLife statement when it announced the buyback Tuesday, "We anticipated that the non-bank SIFI capital rules would be known by now, but recent statements by the Federal Reserve suggest that we may not see draft rules until 2015."

With a return on equity of near 12%, MetLife is well positioned with broad markets and product lines. In addtion to its U.S. business, it has operations in Asia, Europe and Latin America -- 30% of its profits come from international markets.

It also offers a diverse product line. To individuals it offers life insurance and annuities. To corporate employees it provides dental, disability and group life insurance. It also offers guaranteed investment contracts, the stable value offering, to many defined contribution plans. Its 2013 revenue came in at $70.4 billion.

In 2008, MetLife shares were pummeled but it seems management has learned from the experience. The company has begun to reduce sales of variable annuities that offer guarantees, which were a big problem for the company during the financial meltdown. MetLife is also getting out of the long-term care market.

MetLife is a stock to own. Industry experts place a price target of $67 per share, a 22% upside over current market price. With a super low P/E and Price to Book ratio, a great brand name, global reach and a solid and smart management team, MetLife could fly as high as its iconic blimp.

At the time of publication, the author had a position in PRU.

This article represents the opinion of a contributor and not necessarily that of TheStreet or its editorial staff.

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,680.87 +324.00 1.87%
S&P 500 2,049.44 +36.55 1.82%
NASDAQ 4,729.0410 +84.7290 1.82%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs